Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease.

Heinonen, E H

Effects of monoamine oxidase inhibition by selegiline on concentrations of noradrenaline and monoamine metabolites in CSF of patients with Alzheimer's disease. [electronic resource] - Journal of neural transmission. Parkinson's disease and dementia section 1993 - 193-202 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0936-3076

10.1007/BF02257674 doi


Aged
Alzheimer Disease--cerebrospinal fluid
Biogenic Monoamines--cerebrospinal fluid
Double-Blind Method
Female
Humans
Monoamine Oxidase Inhibitors--adverse effects
Norepinephrine--cerebrospinal fluid
Pilot Projects
Psychiatric Status Rating Scales
Selegiline--adverse effects
Tryptophan--cerebrospinal fluid